MedPath

Protective and Risk Factors for QoR-15 for Major Abdominal Surgery

Recruiting
Conditions
Patients Undergoing Major Abdominal Surgery
Registration Number
NCT05980910
Lead Sponsor
National Taiwan University Hospital
Brief Summary

Investigation of post-operative recovery among adult patients receiving major abdominal surgery.

Detailed Description

This prospective observational clinical trial aims to evaluate the postoperative recovery status of patients undergoing major abdominal surgery using the Quality of Recovery-15 (QoR-15) questionnaire. The QoR-15 has been highly regarded for its importance and research value in evaluating postoperative recovery in previous studies and has been validated in numerous languages, including Mandarin. Furthermore, the QoR-15 is not only a reflection of the subjective recovery quality but has also been found to be associated with objective indicators such as postoperative complications. Therefore, establishing a database of postoperative QoR-15 variations can play a significant role in improving healthcare quality and serves as a validation indicator for many Enhanced Recovery After Surgery (ERAS) outcomes. The study aims to contribute to improving postoperative care and inform future research in the context of ERAS programs..

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
350
Inclusion Criteria
  • (1) Age 18years and above.
  • (2) Undergoing elective abdominal surgery with an expected surgical time of at least two hours and an expected hospital stay of at least two days.
Exclusion Criteria
  • (1) Age under 18 years. (2) Incapacity to give informed consent. (3) Emergency surgery.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
QoR-15 Scores at postoperative day one and day three72 hours

Measure the QoR-15(Quality of Recovery-15) scores on the first day and third day after major abdominal surgery. The QoR-15 score, derived from a 15-item questionnaire using an 11-point numeric rating scale, ranges from 0 to 150, with higher scores indicating better recovery quality.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

National Taiwan University Hosipital Hsin Chu Branch

🇨🇳

HsinChu, Taiwan

National Taiwan University Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath